Ierardi E et al. |
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207512
|
Romano C et al. |
Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20148798
|
Itoh S et al. |
Inhibition of CN (protein phosphatase-2B) suppresses Ca2+-mediated acid secretion in rats. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966520
|
Högenauer C et al. |
Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12940927
|
Lawrance IC and Copeland TS |
Rectal tacrolimus in the treatment of resistant ulcerative proctitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18761706
|
Haagsma EB et al. |
Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12848624
|
Ortiz de Frutos FJ |
[New horizons in the treatment of atopic dermatitis]. |
|
Allergol Immunopathol (Madr) |
pmid:11988144
|
Mori F et al. |
Increase of natural killer cells in children with liver transplantation-acquired food allergy. |
|
Allergol Immunopathol (Madr) |
pmid:29456038
|
Regueiro-GarcÃa A et al. |
Haploidentical stem cell transplantation in a boy with chronic granulomatous disease. |
|
Allergol Immunopathol (Madr) |
pmid:29373243
|
Inoue Y et al. |
Food allergy after cord blood stem cell transplantation with tacrolimus therapy in two patients who developed veno-occlusive disease. |
2012 |
Allergol Int |
pmid:22722810
|
Tsuji T et al. |
Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. |
2016 |
Allergol Int |
pmid:26666476
|
Miyachi Y et al. |
Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis: a meta-analysis study. |
2007 |
Allergol Int |
pmid:17582208
|
Ebihara N et al. |
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension. |
2012 |
Allergol Int |
pmid:22361511
|
Yamamoto M et al. |
A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. |
2007 |
Allergol Int |
pmid:17460441
|
Jensen JM et al. |
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis. |
2012 |
Allergy |
pmid:22142306
|
Bieber T et al. |
Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. |
2007 |
Allergy |
pmid:17298428
|
Wollenberg A et al. |
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. |
2008 |
Allergy |
pmid:18592619
|
Bergstrand H and Lundquist B |
Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis-trans isomerase in a secretagogue specific manner. |
1992 |
Allergy |
pmid:1280915
|
Kaufmann R et al. |
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. |
2006 |
Allergy |
pmid:16436149
|
Oldhoff JM et al. |
Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%. |
2006 |
Allergy |
pmid:16629794
|